Amir Abdollahi Selected Research

Carbon

2/2024	Understanding RBE and clinical outcome of prostate cancer therapy using particle irradiation: analysis of tumor control probability with mMKM.
12/2022	Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model.
10/2022	Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions.
10/2022	FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model.
9/2022	Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
1/2022	Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy.
1/2022	Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells.
12/2021	Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model.
5/2021	Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions.
12/2020	Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amir Abdollahi Research Topics

Disease

91	Neoplasms (Cancer) 04/2024 - 07/2003
22	Squamous Cell Carcinoma of Head and Neck 12/2023 - 12/2014
20	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 11/2004
13	Glioma (Gliomas) 01/2022 - 12/2003
12	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2005
11	Hypoxia (Hypoxemia) 01/2023 - 07/2012
9	Fibrosis (Cirrhosis) 01/2021 - 10/2004
7	Lung Neoplasms (Lung Cancer) 12/2020 - 07/2012
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 01/2011
6	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 06/2009
6	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 07/2003
6	Meningioma (Meningiomas) 01/2023 - 03/2008
6	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 01/2016
5	Carcinoma (Carcinomatosis) 04/2021 - 07/2006
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2018 - 07/2006
3	AIDS-Related Complex (ARC) 10/2022 - 05/2021
3	Adenocarcinoma 10/2022 - 05/2022
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2010 - 03/2005
2	Radiation Fibrosis Syndrome (Radiation Fibrosis) 03/2022 - 03/2006
2	Lymphoma (Lymphomas) 01/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 09/2020 - 07/2018
2	Adenocarcinoma of Lung 01/2020 - 01/2017
2	Inflammation (Inflammations) 04/2016 - 12/2009
2	Carcinogenesis 01/2016 - 07/2012
2	Body Weight (Weight, Body) 03/2007 - 01/2006
1	Radiation Pneumonitis 01/2024
1	Unilateral Breast Neoplasms 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2024

Drug/Important Bio-Agent (IBA)

25	IonsIBA 04/2024 - 05/2012
23	CarbonIBA 02/2024 - 05/2012
15	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2015
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
13	Protons (Proton)IBA 02/2024 - 05/2012
12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2014
9	HeliumIBA 04/2024 - 08/2016
6	Messenger RNA (mRNA)IBA 11/2021 - 02/2009
6	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 12/2014
6	Angiogenesis InhibitorsIBA 02/2010 - 07/2003
5	RNA (Ribonucleic Acid)IBA 12/2022 - 06/2009
4	Oxygen (Dioxygen)IBA 09/2022 - 08/2016
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 09/2011
4	Radiation-Sensitizing AgentsIBA 01/2022 - 01/2011
4	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 09/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2008
4	Semaxinib (SU5416)IBA 04/2008 - 07/2003
3	Gemcitabine FDA Link 04/2024 - 03/2012
3	Phosphotransferases (Kinase)IBA 11/2021 - 03/2007
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021 - 03/2006
3	MicroRNAs (MicroRNA)IBA 03/2021 - 01/2012
3	KinesinsIBA 01/2021 - 06/2009
3	Small Interfering RNA (siRNA)IBA 04/2019 - 06/2009
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 01/2006
3	Tyrosine Kinase InhibitorsIBA 02/2015 - 03/2007
3	Imatinib Mesylate (Gleevec)FDA Link 12/2009 - 03/2006
3	Platelet-Derived Growth FactorIBA 04/2008 - 03/2005
3	orantinib (SU6668)IBA 04/2008 - 07/2003
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2019
2	Immune Checkpoint InhibitorsIBA 12/2022 - 09/2020
2	VaccinesIBA 12/2022 - 01/2005
2	LigandsIBA 05/2022 - 08/2017
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 02/2009
2	Cetuximab (Erbitux)FDA Link 05/2022 - 07/2018
2	Amino Acids FDA Link 01/2022 - 01/2021
2	PPAR gammaIBA 01/2021 - 05/2010
2	EnzymesIBA 11/2019 - 01/2014
2	Caspase 3 (Caspase-3)IBA 01/2019 - 05/2005
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 02/2015
2	ParaffinIBA 01/2018 - 05/2016
2	Formaldehyde (Formol)FDA Link 01/2018 - 05/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 06/2010
2	Protein Kinases (Protein Kinase)IBA 12/2017 - 01/2014
2	AntigensIBA 01/2017 - 01/2005
2	CrizotinibIBA 02/2016 - 02/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2014 - 06/2008
2	Tissue Inhibitor of Metalloproteinase-3IBA 01/2012 - 02/2009
2	AngiomotinsIBA 01/2012 - 01/2012
2	ThrombospondinsIBA 01/2012 - 02/2009
2	Growth Factor ReceptorsIBA 01/2012 - 02/2010
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011 - 01/2006
2	Celecoxib (Celebrex)FDA Link 01/2011 - 01/2006
2	matrigelIBA 05/2010 - 07/2003
2	PDGF receptor tyrosine kinaseIBA 12/2009 - 03/2005
2	AngiostatinsIBA 08/2009 - 02/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2009 - 07/2003
2	SU 11657IBA 03/2008 - 05/2005
1	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 11/2023
1	5- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA 11/2023
1	pexidartinibIBA 11/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2023
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 11/2023

Therapy/Procedure

50	Therapeutics 04/2024 - 12/2003
44	Radiotherapy 04/2024 - 07/2003
18	Chemoradiotherapy 01/2023 - 12/2014
17	Drug Therapy (Chemotherapy) 04/2024 - 11/2004
7	Heavy Ion Radiotherapy 02/2024 - 01/2018
6	Immunotherapy 01/2022 - 01/2005
2	Neoadjuvant Therapy 05/2016 - 03/2012
1	Mastectomy (Mammectomy) 01/2024
1	Proton Therapy 01/2024
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024